Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Passage Bio, Inc. (PASG) had Return on Investments of -24.53% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.38M |
|
-- |
|
-- |
|
$10.33M |
|
$-10.33M |
|
$0.95M |
|
$-9.38M |
|
$-9.38M |
|
$-9.38M |
|
$-9.38M |
|
$-9.38M |
|
$-9.38M |
|
$-10.33M |
|
$-10.16M |
|
3.17M |
|
3.17M |
|
$-2.96 |
|
$-2.96 |
|
| Balance Sheet Financials | |
$60.31M |
|
$5.34M |
|
$18.88M |
|
$79.20M |
|
$19.80M |
|
-- |
|
$21.14M |
|
$40.94M |
|
$38.26M |
|
$38.26M |
|
$38.26M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-20.18M |
|
$40.22M |
|
$0.01M |
|
$37.57M |
|
$57.63M |
|
$20.05M |
|
$1.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.53% |
|
-24.53% |
|
-11.85% |
|
|
Return on Investments |
-24.53% |
$12.03 |
|
$-6.00 |
|
$-6.37 |
|